These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 28927237
1. Augmented Association Between Blood Pressure and Proteinuria in Hyperuricemic Patients With Nonnephrotic Chronic Kidney Disease. Kohagura K, Kochi M, Miyagi T, Zamami R, Nagahama K, Yonemoto K, Ohya Y. Am J Hypertens; 2018 Mar 10; 31(4):480-485. PubMed ID: 28927237 [Abstract] [Full Text] [Related]
2. Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease. Zamami R, Kohagura K, Miyagi T, Kinjyo T, Shiota K, Ohya Y. J Hypertens; 2016 Nov 10; 34(11):2274-9. PubMed ID: 27607459 [Abstract] [Full Text] [Related]
3. Effects of topiroxostat in hyperuricemic patients with chronic kidney disease. Horino T, Hatakeyama Y, Ichii O, Matsumoto T, Shimamura Y, Inoue K, Terada Y, Okuhara Y. Clin Exp Nephrol; 2018 Apr 10; 22(2):337-345. PubMed ID: 28752287 [Abstract] [Full Text] [Related]
4. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, Sakima A, Iseki K, Ohya Y. Hypertens Res; 2013 Jan 10; 36(1):43-9. PubMed ID: 22951520 [Abstract] [Full Text] [Related]
5. Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia. Lebensburger JD, Cutter GR, Howard TH, Muntner P, Feig DI. Pediatr Nephrol; 2017 Sep 10; 32(9):1565-1573. PubMed ID: 28382567 [Abstract] [Full Text] [Related]
6. Association of blood pressure and hyperuricemia with proteinuria and reduced renal function in the general population. Kochi M, Kohagura K, Oshiro N, Zamami R, Nagahama K, Nakamura K, Ohya Y. Hypertens Res; 2023 Jul 10; 46(7):1662-1672. PubMed ID: 36991065 [Abstract] [Full Text] [Related]
7. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study. Gunawardhana L, McLean L, Punzi HA, Hunt B, Palmer RN, Whelton A, Feig DI. J Am Heart Assoc; 2017 Nov 04; 6(11):. PubMed ID: 29102979 [Abstract] [Full Text] [Related]
8. Is increased uric acid a risk factor or a defensive response? The Campania Salute Network. Mancusi C, Izzo R, Ferrara LA, Rozza F, Losi MA, Canciello G, Pepe M, de Luca N, Trimarco B, de Simone G. Nutr Metab Cardiovasc Dis; 2018 Aug 04; 28(8):839-846. PubMed ID: 29898822 [Abstract] [Full Text] [Related]
9. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T. Hypertens Res; 2009 Dec 04; 32(12):1123-9. PubMed ID: 19816503 [Abstract] [Full Text] [Related]
10. Effect of hyperuricemia on the blood pressure response to antihypertensive agents in hospitalized elderly patients. Zhu P, Lin F, Lin C, Hong D, Lin K, Chen H. J Cardiovasc Med (Hagerstown); 2012 Nov 04; 13(11):741-6. PubMed ID: 22964647 [Abstract] [Full Text] [Related]
11. Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study. Redon P, Maloberti A, Facchetti R, Redon J, Lurbe E, Bombelli M, Mancia G, Grassi G. J Hypertens; 2019 Feb 04; 37(2):380-388. PubMed ID: 30074564 [Abstract] [Full Text] [Related]
12. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ. Am J Kidney Dis; 2015 Dec 04; 66(6):984-92. PubMed ID: 26209544 [Abstract] [Full Text] [Related]
13. Body mass index, fat free mass, uric acid, and renal function as blood pressure levels determinants in young adults. Sidoti A, Nigrelli S, Rosati A, Bigazzi R, Caprioli R, Fanelli R, Acconcia P, Borracelli D, Biagioli M, Angelini D, Parrini M, Tonelli L, Tosi P, Manzoni D. Nephrology (Carlton); 2017 Apr 04; 22(4):279-285. PubMed ID: 26990793 [Abstract] [Full Text] [Related]
14. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial. Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y, FEATHER Study Investigators. Am J Kidney Dis; 2018 Dec 04; 72(6):798-810. PubMed ID: 30177485 [Abstract] [Full Text] [Related]
15. Blood pressure control and kidney damage in hypertension: Results of a three-center cross-sectional study in North Central Nigeria. Abene EE, Gimba ZM, Edah JO, Akinbuwa BA, Uchendu DG, Onyenuche C, Ojo OS, Tzamaloukas AH, Agaba EI. Niger J Clin Pract; 2020 Nov 04; 23(11):1590-1597. PubMed ID: 33221787 [Abstract] [Full Text] [Related]
16. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease. Ghane Sharbaf F, Assadi F. Pediatr Nephrol; 2018 Aug 04; 33(8):1405-1409. PubMed ID: 29549464 [Abstract] [Full Text] [Related]
17. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus. Viazzi F, Piscitelli P, Ceriello A, Fioretto P, Giorda C, Guida P, Russo G, De Cosmo S, Pontremoli R, AMD‐Annals Study Group. J Am Heart Assoc; 2017 Sep 22; 6(9):. PubMed ID: 28939716 [Abstract] [Full Text] [Related]
19. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ. Clin J Am Soc Nephrol; 2011 Aug 22; 6(8):1887-94. PubMed ID: 21784838 [Abstract] [Full Text] [Related]
20. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. Momoki K, Kataoka H, Moriyama T, Mochizuki T, Nitta K. J Atheroscler Thromb; 2017 Jun 01; 24(6):630-642. PubMed ID: 27784849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]